1-3 of 3
Authors: Alan Sandler
Sort by
Journal Article
A Randomized Phase II Study of Carboplatin With Weekly or Every-3-Week Nanoparticle Albumin-Bound Paclitaxel (Abraxane) in Patients With Extensive-Stage Small Cell Lung Cancer
Juneko E. Grilley-Olson and others
The Oncologist, Volume 20, Issue 2, February 2015, Pages 105–106, https://doi.org/10.1634/theoncologist.2014-0327
Published: 23 January 2015
Journal Article
Bevacizumab and Erlotinib: A Promising New Approach to the Treatment of Advanced NSCLC
Roy S. Herbst and Alan Sandler
The Oncologist, Volume 13, Issue 11, November 2008, Pages 1166–1176, https://doi.org/10.1634/theoncologist.2008-0108
Published: 08 November 2008
Journal Article
Gemcitabine: Single-Agent and Combination Therapy in Non-Small Cell Lung Cancer
Alan Sandler and David S. Ettinger
The Oncologist, Volume 4, Issue 3, June 1999, Pages 241–251, https://doi.org/10.1634/theoncologist.4-3-241
Published: 01 June 1999
Advertisement
Advertisement